PEG-ADA2

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePEG-ADA2
Drug Alias NamePEGylated adenosine deaminase 2 (Halozyme Therapeutics)PEG-ADA2-R222Q-S265NPEG-ADA2-K374DPEG-ADA2
ClassificationSmall molecules
Mechanisms of ActionAdenosine deaminase inhibitorsImmunosuppressants
TargetsAdenosine deaminase
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHalozyme Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHalozyme Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A